Health, Fitness, and Safety Knowledge as Determinants of Adverse Events in Recreational Divers in Poland (DIVE-PL)

October 1, 2026 updated by: Medical University of Bialystok

Health Status, Physical Activity, and Safety Knowledge as Determinants of Adverse Events Among Recreational Divers in Poland: a Cross-sectional Online Survey Study

This cross-sectional online survey study assesses health status, physical fitness, and safety knowledge as potential determinants of diving-related adverse events among recreational divers in Poland. Recreational diving exposes participants to specific hazards, including decompression sickness (DCS) and barotrauma of the middle ear, sinuses, and lungs. To date, no Polish study has simultaneously evaluated health, physical fitness, theoretical safety knowledge, and the occurrence of adverse events in this population. Adult divers (18 years or older) who completed at least one dive in the past 24 months and reside in Poland complete an anonymous online questionnaire (about 12 to 18 minutes). Physical fitness is estimated as VO2max using the University of Houston Non-Exercise Test (physical activity rating, age, BMI, and sex). Knowledge of DCS, barotrauma, and safe-diving rules is tested at three difficulty levels. The questionnaire also captures diving exposure, certification level, chronic health conditions, and risky behaviours (smoking, alcohol use, and diving beyond certification). The primary endpoint is the proportion of divers reporting at least one diving-related adverse event. Associations with certification level, estimated VO2max, BMI, and other factors are analysed using multivariable logistic regression. The study is non-interventional, anonymous, and carries minimal risk; no clinical procedures or biological sampling are involved.

Study Overview

Status

Not yet recruiting

Detailed Description

Primary objective: to assess health status, physical fitness, and safety/training knowledge in relation to the occurrence of diving-related adverse events among recreational divers in Poland.

Specific objectives: (1) estimate VO2max from the University of Houston Non-Exercise Test; (2) assess knowledge of decompression sickness, barotrauma, and safe-diving rules at basic, advanced, and emergency-medical levels; (3) determine the frequency of barotrauma and decompression sickness symptoms (clinically confirmed versus presumed); (4) identify risky behaviours (smoking, alcohol use, diving under the influence, and diving beyond certification); (5) assess associations between training level, physical activity, and health and the occurrence of adverse events using multivariable logistic regression.

Hypotheses: H1 - higher certification (Advanced Open Water Diver and above) is associated with better knowledge of diving-related health hazards; H2 - lower estimated VO2max is associated with a higher frequency of adverse events; H3 - risky behaviours are more frequent among lower-certified divers; H4 (exploratory) - decompression sickness risk factors identified in the DAN DSL 2024 dataset are present in the Polish recreational diving population.

Design: cross-sectional, observational, non-interventional study conducted as an anonymous online survey. No clinical procedures, biological sampling, or modification of medical management are involved.

Population and sampling: adults (18 years or older) residing in Poland who completed at least one dive in the past 24 months, recruited online (convenience sampling) via diving organizations, dive centers, and themed social-media communities.

Sample size: target analytic n = 384, derived by triangulation of three methods (proportion estimation n = 323; two-proportion comparison n = 304; logistic-regression events-per-variable rule n = 234), with the binding value (323) plus a 15% non-response buffer.

Data collection and privacy: anonymous online questionnaire hosted on Medical University of Bialystok infrastructure (REDCap); no identifying data and no IP address are stored; processing is GDPR-compliant; data are retained on secured university storage for 5 years and used only for aggregate scientific analysis.

Study Type

Observational

Enrollment (Estimated)

384

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Podlaskie Voivodeship
      • Bialystok, Podlaskie Voivodeship, Poland, 15-540
        • Medical University of Bialystok, Department of Respiratory Physiopathology
        • Contact:
      • Bialystok, Podlaskie Voivodeship, Poland, 15-540
        • Medical University of Bialystok, II Department of Lung Diseases, Lung Cancer and Internal Medicine
        • Contact:
          • Robert Mróz, Prof. MD PhD
          • Phone Number: +48858316383
          • Email: lung@umb.edu.pl
        • Sub-Investigator:
          • Jakub Matuk, BEng

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult recreational divers residing in Poland who completed at least one dive in the past 24 months, recruited online (convenience sampling) via diving organizations (KDP/CMAS-PTTK, PADI, SSI, IANTD, RAID), dive centers, and themed social-media communities.

Description

Inclusion Criteria:

  • Age 18 years or older
  • At least one dive within the past 24 months
  • Provision of informed consent (checkbox in the survey)
  • Residence in Poland (self-declared)

Exclusion Criteria:

  • Age under 18 years
  • No dive within the past 24 months
  • No consent to participate
  • Incomplete completion of survey sections A-C (eligibility, demographics, diving exposure)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: CROSS_SECTIONAL

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Recreational divers

Adults (18 years or older) residing in Poland who completed at least one dive in the past 24 months and complete the anonymous online survey. A single observational cohort assessed cross-sectionally.

Anonymous online questionnaire completed once by each participant (about 12 to 18 minutes). It captures demographic data, diving exposure and certification level, chronic health conditions, risky behaviours, estimated VO2max (University of Houston Non-Exercise Test), and a diving-safety knowledge test. No clinical procedures or biological sampling are involved; this is the observational data-collection instrument for the cohort.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of diving-related adverse events
Time Frame: At enrollment (Day 1; single cross-sectional assessment)

Proportion of divers reporting at least one diving-related adverse event (barotrauma symptoms, decompression sickness symptoms, or other post-dive health problems) occurring at any time during the participant's diving history up to enrollment (lifetime recall). Reported as a percentage with 95% confidence interval.

At enrollment (Day 1; single cross-sectional assessment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Estimated VO2max (University of Houston Non-Exercise Test)
Time Frame: At enrollment (Day 1; single cross-sectional assessment)

Estimated maximal oxygen uptake (mL/kg/min) calculated from the University of Houston Non-Exercise Test (physical activity rating, age, BMI, and sex), summarized as mean with standard deviation and as median with quartiles, stratified by sex and age.

At enrollment (Day 1; single cross-sectional assessment)
Diving safety knowledge score
Time Frame: At enrollment (Day 1; single cross-sectional assessment)

Percentage of correct answers on the diving-hazard knowledge test (decompression sickness, barotrauma, and safe-diving rules), reported overall and at three difficulty levels: basic, advanced, and emergency-medical.

At enrollment (Day 1; single cross-sectional assessment)
Frequency of risky behaviours
Time Frame: At enrollment (Day 1; single cross-sectional assessment)

Proportion of divers reporting risky behaviours: tobacco use, alcohol use before diving, diving under the influence of alcohol or other substances, and diving beyond their certification level.

At enrollment (Day 1; single cross-sectional assessment)
Adjusted odds ratios for diving-related adverse events
Time Frame: At enrollment (Day 1; single cross-sectional assessment)

Adjusted odds ratios (with 95% confidence intervals) for the occurrence of at least one diving-related adverse event, estimated by multivariable logistic regression, for certification level, estimated VO2max, BMI, and selected risk factors from the DAN DSL 2024 dataset (e.g., sex, thermal comfort, pre-dive physical activity).

At enrollment (Day 1; single cross-sectional assessment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

October 31, 2027

Study Completion (Estimated)

October 31, 2027

Study Registration Dates

First Submitted

July 2, 2026

First Submitted That Met QC Criteria

October 1, 2026

First Posted (Actual)

October 2, 2026

Study Record Updates

Last Update Posted (Actual)

October 2, 2026

Last Update Submitted That Met QC Criteria

October 1, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe